Contact
searchSearch
HMP Global

Advertisement

Publications

Specialty

Journal of Clinical Pathways
The Value of Tissue-Based Genomic Profiling in Oncology
09/17/2024
Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.
First Report Managed Care
Obesity Significantly Increases Cancer Risk in Patients With Cardiovascular Disease
09/16/2024
Obesity is associated with an increased cancer risk in patients with cardiovascular disease (CVD), highlighting the need for targeted prevention strategies, according to study results published in the Journal of the American Heart Association.
Pharmacy Learning Network
Revolutionary Cell Therapy May Eliminate Need for Immunosuppressants in Liver Transplant Recipients
09/16/2024
Donor immune cells may reduce or eliminate the need for immunosuppressants in liver transplant recipients, potentially revolutionizing post-transplant care, according to a study published in Science Translational Medicine.
The Dermatologist
Lebrikizumab FDA Approved for Moderate to Severe Atopic Dermatitis in Adults and Children
09/16/2024
The US Food and Drug Administration has approved Eli Lilly’s EBGLYSS (lebrikizumab-lbkz), an IL-13 inhibitor, for the treatment of moderate to severe atopic dermatitis in adults and children.
First Report Managed Care
CDC Invests $400 Million to Accelerate HIV Prevention and Surveillance Efforts Nationwide
09/16/2024
The Centers for Disease Control and Prevention (CDC) has awarded $400 million in funding to boost HIV prevention and surveillance efforts across the United States, aiming to accelerate progress in reducing new infections and improving health outcomes for those affected by HIV.
Pharmacy Learning Network
South Carolina Pharmacist Sentenced for Illegally Compounding Radioactive Drugs
09/16/2024
The United States Attorney’s Office for the District of South Carolina has announced that a pharmacist pleaded guilty to adulteration of a radioactive drug and has been sentenced. Access the Pharmlaw to view details of the case.
ePlasty, Surgery
Efficacy and Safety of Barbed Sutures for Capsulorrhaphy in Implant-Based Breast Reconstruction
09/16/2024
This study compares barbed versus smooth sutures for capsulorrhaphy in breast reconstruction, focusing on safety, efficiency, and outcomes.
ePlasty
Can ChatGPT Be Used as a Research Assistant and a Patient Consultant in Plastic Surgery? A Review of 3 Key Information Domains
09/16/2024
This review assessed ChatGPT's role in plastic surgery, focusing on research generation, medical literature summarization, and patient consultation capabilities.
EP Lab Digest
BIOTRONIK Receives FDA Approval for LBBAP Indication on Pacing Lead and Delivery Catheter System
09/16/2024
BIOTRONIK Press Release
Vascular Disease Management, CardioVascular
What Is the Impact of Amputation as a Treatment for CLI? Economic Costs and Patient Consequences
09/16/2024
Watch as Mary Yost, MBA, cofounder of The Yost Group, discusses her AMP 2024 presentation on the consequences of amputation as a treatment for patients with critical limb ischemia.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular, Vascular Disease Management
Shockwave Medical Expands U.S. Peripheral IVL Portfolio with Enhanced Catheter
09/16/2024
The Shockwave E8 catheter is designed to optimize the treatment of patients with calcified femoro-popliteal and below-the-knee peripheral artery disease (PAD), including patients with complex chronic limb-threatening ischemia (CLTI).  
Vascular Disease Management, CardioVascular
Argon Medical Launches CLEANER Vac™ Thrombectomy System to Remove Blood Clot in the Peripheral Venous Vasculature
09/16/2024
PLANO, Texas, Sept. 16, 2024 /PRNewswire/ -- Argon Medical Devices, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology procedures, announced the launch of the CLEANER Vac™ Thrombectomy System for the removal of blood clot from the peripheral venous vasculature.
Oncology
Study Suggests Retifanlimab Plus Chemotherapy as New Standard of Care for Locally Recurrent or Metastatic Anal Cancer
09/16/2024
Sheela Rao, MBBS, MD, discusses results from the phase 3 POD1UM-303/InterAACT 2 study which showed encouraging efficacy with retifanlimab added to standard of care chemotherapy in patients with locally recurrent or metastatic squamous cell carcinoma of the anal canal.
Oncology
First-Line Capivasertib Plus Paclitaxel Fails to Improve OS in Metastatic Triple-Negative Breast Cancer
09/16/2024
Heather McArthur, MD, discusses results from the phase 3 CAPItello-290 trial which evaluated capivasertib plus paclitaxel as first-line treatment for patients with metastatic triple-negative breast cancer.
Oncology
Belrestotug Added to Dostarlimab Demonstrates Antitumor Activity in PD-L1-High Locally Advanced or Metastatic Non-Small Cell Lung Cancer
09/16/2024
Results from the phase 2 GALAXIES Lung-201 study show the addition of belrestotug to dostarlimab demonstrates antitumor activity among patients with PD-L1-high locally advanced or metastatic non-small cell lung cancer.
Oncology
Durvalumab Added to Neoadjuvant Chemotherapy Improves Survival Outcomes in Muscle-Invasive Bladder Cancer: NIAGARA Trial
09/15/2024
The NIAGARA trial showed that durvalumab plus neoadjuvant chemotherapy improved EFS and OS compared to neoadjuvant chemotherapy alone in patients with muscle-invasive bladder cancer.
Oncology
Neoadjuvant Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for High-Risk, Early-Stage Triple-Negative Breast Cancer
09/15/2024
The KEYNOTE-522 trial demonstrated a statistically significant and clinically meaningful improvement in OS with the addition of pembrolizumab to neoadjuvant chemotherapy for patients with high-risk, early-stage triple-negative breast cancer.
Oncology
Hypofractionated vs Normofractionated Radiation Therapy for Early-Stage Breast Cancer
09/15/2024
Results from the phase 3 HypoG-01 trial show hypofractionated locoregional radiation therapy is non-inferior to normofractionated radiation therapy in terms of arm lymphedema risk in early breast cancer and did not lead to unfavorable study outcomes.
The Dermatologist
QUIZ: Psoriasis and Atopic Dermatitis: Nonsteroidal Topical Therapies
09/15/2024
1.
Oncology
Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab Improves Survival in Early-Stage Triple-Negative Breast Cancer
09/15/2024
Peter Schmid, MD, PhD, discusses results from the phase 3 KEYNOTE-522 study which demonstrated significantly improved overall survival with neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab for patients with high-risk, early-stage triple-negative breast cancer.

Advertisement

Subscribe and never miss an article!

Today's Wound Clinic Newsletter

Letter From the Editor

Guest Editorial
Advocate for Your Wound Care Patients on the Proposed MAC Policy on CTPs
05/29/2024
Eric J. Lullove, DPM, CWSP
The MACs recently released proposed coverage policy updates for applying CTPs for DFUs and VLUs. This is your opportunity to effect change by submitting comments to the MACs before the policy becomes final. You have a responsibility to know...
The MACs recently released proposed coverage policy updates for applying CTPs for DFUs and VLUs. This is your opportunity to effect change by submitting comments to the MACs before the policy becomes final. You have a responsibility to know...
The MACs recently released...
05/29/2024
Today's Wound Clinic
From the Editor
The Future of Wound Care in the Quality Payment Program
03/13/2024
Whether we will be able to survive as wound care practitioners will, at least in part, depend on having quality measures that are relevant to what we actually do.
Whether we will be able to survive as wound care practitioners will, at least in part, depend on having quality measures that are relevant to what we actually do.
Whether we will be able to...
03/13/2024
Today's Wound Clinic
From the Editor
The Non-Pressure Ulcer Episode-Based Cost Measure "Field Test" Began Feb. 1
02/05/2024
For years I have been explaining how the QPP could be the end of wound care practitioners. The entire QPP is designed around recognized medical specialties and since there is no recognized specialty for wound care, we are all in trouble.
For years I have been explaining how the QPP could be the end of wound care practitioners. The entire QPP is designed around recognized medical specialties and since there is no recognized specialty for wound care, we are all in trouble.
For years I have been explaining...
02/05/2024
Today's Wound Clinic
Guest Editorial
The G-Code Solution to Skin Substitute Reimbursement
01/25/2024
I am calling on CMS to adopt new G codes to replace Q code reimbursement and CPT 15000 codes for skin substitute application procedures and to establish skin substitute product code classes.
I am calling on CMS to adopt new G codes to replace Q code reimbursement and CPT 15000 codes for skin substitute application procedures and to establish skin substitute product code classes.
I am calling on CMS to adopt new...
01/25/2024
Today's Wound Clinic
Guest Editorial
Wound Size Matters: Analysis of the New Restrictive Skin Substitute LCD Policy
09/01/2023
With so much ambiguity remaining, an immediate compromise on the number of applications to allow 7 is warranted both from an ethical and medical perspective. The current restriction of 4 applications is clearly not based on an accurate...
With so much ambiguity remaining, an immediate compromise on the number of applications to allow 7 is warranted both from an ethical and medical perspective. The current restriction of 4 applications is clearly not based on an accurate...
With so much ambiguity...
09/01/2023
Today's Wound Clinic
Guest Editorial
Wrestling With Implicit Bias to Deliver Better Care for Our Patients
06/01/2023
For some, bias remains a sensitive issue, and some people are reluctant to admit to the need for introspection. However, to mitigate the ill effects of bias, everyone must first acknowledge that it exists.
For some, bias remains a sensitive issue, and some people are reluctant to admit to the need for introspection. However, to mitigate the ill effects of bias, everyone must first acknowledge that it exists.
For some, bias remains a...
06/01/2023
Today's Wound Clinic
From the Editor
Confessions of a Doctor With Lipedema
03/14/2023
It is hard to understand how demoralizing it is. Lipedema affects your entire life, starting in the teenage years.
It is hard to understand how demoralizing it is. Lipedema affects your entire life, starting in the teenage years.
It is hard to understand how...
03/14/2023
Today's Wound Clinic
From the Editor
Why Won’t the DME Provide Dressings for My Patient?
02/23/2023
Maybe Because Of My Documentation
Maybe Because Of My Documentation
Maybe Because Of My...
02/23/2023
Today's Wound Clinic
Guest Editorial
How Wound Care Providers Can Treat Patients Like People, Not Like Cases
02/01/2023
Finding a skilled wound care professional comes down finding someone who is confident in their skill/craft—someone who treats the whole patient, not just the wound. Finding someone who would see me as a person and a whole being rather than...
Finding a skilled wound care professional comes down finding someone who is confident in their skill/craft—someone who treats the whole patient, not just the wound. Finding someone who would see me as a person and a whole being rather than...
Finding a skilled wound care...
02/01/2023
Today's Wound Clinic
Guest Editorial
Amputations in Pyoderma Gangrenosum Patients: Underreported or Very Rare?
01/11/2023
Are providers missing the diagnosis of PG because they are anchoring on “positive” biopsy findings? Could we be missing cases in which PG patients underwent amputation, didn’t have a recurrence, and were never diagnosed? Or are we just not...
Are providers missing the diagnosis of PG because they are anchoring on “positive” biopsy findings? Could we be missing cases in which PG patients underwent amputation, didn’t have a recurrence, and were never diagnosed? Or are we just not...
Are providers missing the...
01/11/2023
Today's Wound Clinic

Advertisement

Coping With COVID-19

Business Briefs
Telehealth Use Continues and Receives Further Medicare Payment 
01/25/2023
The COVID-19 PHE has been extended for 90 more days. This author reviews the Medicare telehealth flexibility extensions that may be important to wound/ulcer management professionals.
The COVID-19 PHE has been extended for 90 more days. This author reviews the Medicare telehealth flexibility extensions that may be important to wound/ulcer management professionals.
The COVID-19 PHE has been...
01/25/2023
Today's Wound Clinic
Business Briefs
The COVID-19 Public Health Emergency Waivers Q&A
09/07/2022
This author answers more questions about what will happen to telehealth and other waivers when the COVID-19 PHE ends.
This author answers more questions about what will happen to telehealth and other waivers when the COVID-19 PHE ends.
This author answers more...
09/07/2022
Today's Wound Clinic
Business Briefs
The COVID-19 Public Health Emergency Extension Also Applies to Telehealth
08/15/2022
The COVID-19 Public Health Emergency (PHE) is extended through October 13, 2022. Many wound/ulcer management professionals have been using telehealth and should be happy to know that the Medicare waivers pertaining to telehealth have also...
The COVID-19 Public Health Emergency (PHE) is extended through October 13, 2022. Many wound/ulcer management professionals have been using telehealth and should be happy to know that the Medicare waivers pertaining to telehealth have also...
The COVID-19 Public Health...
08/15/2022
Today's Wound Clinic
Business Briefs
The COVID-19 Public Health Emergency, Coding Changes, and Coverage Changes Continue
02/09/2022
For this month, let us review the continuation of the COVID-19 public health emergency (PHE), and the continuation of the ever-changing codes and coverage.
For this month, let us review the continuation of the COVID-19 public health emergency (PHE), and the continuation of the ever-changing codes and coverage.
For this month, let us review...
02/09/2022
Today's Wound Clinic

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use